Neurology India
Open access journal indexed with Index Medicus
  Users online: 415  
 Home | Login 
  About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe Etcetera Contact  
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,177 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Methodology
 » Results
 » Discussion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed674    
    Printed23    
    Emailed0    
    PDF Downloaded52    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2017  |  Volume : 65  |  Issue : 1  |  Page : 52-57

Sonothrombolysis for acute ischemic stroke - Break on through to the other side


1 Department of Neurological Sciences, Neurology Unit, Christian Medical College, Vellore, Tamil Nadu, India
2 Department of Radiology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India

Date of Web Publication12-Jan-2017

Correspondence Address:
Mathew Alexander
Department of Neurological Sciences, Neurology Unit, Christian Medical College, Vellore - 632 004, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.198213

Rights and Permissions

 » Abstract 

Background: Intravenous (IV) tissue plasminogen activator (tPA) infusion combined with transcranial low-frequency ultrasound waves targeted on the occluded arterial segment (sonothrombolysis) can increase recanalization in large artery-acute ischemic stroke (LA-AIS).
Aims: To evaluate the benefits of sonothrombolysis in LA-AIS.
Settings and Designs: An open-labeled observational study done in a quaternary care teaching hospital.
Methodology: Patients with LA-AIS within the window period (<4.5 h) with no contraindications for IV-recombinant tPA were sonothrombolysed. Recanalization was monitored and graded using the transcranial Doppler thrombolysis in brain ischemia (TIBI) flow criteria and also by time of flight magnetic resonance angiography using a modified thrombolysis in myocardial infarction score. Parenchymal changes were assessed using computed tomography (CT) or diffusion-weighted imaging-Alberta Stroke Programme Early CT Score. National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) were used to assess the outcome.
Results: Eighteen patients underwent sonothrombolysis and the mean onset to needle time was 138 min (range 65–256). TIBI residual flow grade of ≥2 was seen in 15 of 18 patients (83%). Immediate dramatic improvement (NIHSS score ≤3 points or improvement by ≥10 points) was seen in 6 of 18 patients (30%) and in 9 of 18 patients (50%) within the next 24 h. Two patients (one with TIBI 0, another with re-occlusion) underwent mechanical thrombectomy post-sonothrombolysis. Symptomatic hemorrhage occurred in 5.5% of the patients. At 6 months, 2 of 18 patients (11%) died and 10 of 16 patients (63%) achieved mRS ≤2.
Conclusions: Sonothrombolysis appears to be a safe way to augment the effect of tPA without increasing the door to needle time with the added advantage of observing flow through the occluded artery in real time.


Keywords: Acute ischemic stroke, developing countries, sonothrombolysis, tissue plasminogen activator, transcranial Doppler ultrasound
Key Message:
Sonothrombolysis can be used as an adjuvant therapy in patients receiving IV thrombolysis and can also monitor recanalization.


How to cite this article:
Aaron S, Mani S, Prabhakar A T, Babu P S, Kumar S, Benjamin RN, Sivadasan A, Muthusamy K, Patil AK, Mathew V, Alexander M. Sonothrombolysis for acute ischemic stroke - Break on through to the other side. Neurol India 2017;65:52-7

How to cite this URL:
Aaron S, Mani S, Prabhakar A T, Babu P S, Kumar S, Benjamin RN, Sivadasan A, Muthusamy K, Patil AK, Mathew V, Alexander M. Sonothrombolysis for acute ischemic stroke - Break on through to the other side. Neurol India [serial online] 2017 [cited 2017 May 23];65:52-7. Available from: http://www.neurologyindia.com/text.asp?2017/65/1/52/198213


The treatment of acute ischemic strokes (AISs) is primarily aimed at recanalization and restoring the blood flow. Treatment with intravenous (IV) tissue plasminogen activator (tPA) is an approved therapy for arterial recanalization in AIS.[1]

Understandably, the strongest predictor for a favorable outcome following ischemic strokes due to a large vessel occlusion is the recanalization achieved within the shortest possible time.[2] However, even if given well within the window period, IV tPA does not guarantee recanalization in all cases of AIS. Bhatia et al.,[3] showed a low rate (21%) of acute recanalization with IV tPA, especially with proximal vessel occlusions.

Recent trials have shown the superiority of second-generation mechanical thrombectomy devices over IV thrombolysis for anterior circulation ischemic strokes caused by large artery (LA) occlusion.[4],[5],[6] However, in many developing countries like ours, mechanical thrombectomy is not yet widely available and IV thrombolysis may be the only treatment option available.

Ultrasound targeting of the occluded artery in combination with IV tPA (sonothrombolysis) has been shown to increase the rate of recanalization, both through its direct mechanical effect on the thrombus and indirectly by augmenting the effect of tPA on the clot. Sonothrombolysis is safe and does not add to the door to needle time. In addition, one has the added advantage of observing the flow through the occluded artery in real time. It does not involve sophisticated equipment or intensive training.

Here, we present a series of AIS caused by large vessel occlusion which were treated using sonothrombolysis. To the best of our knowledge, this is the first such case series from the Indian subcontinent.


 » Methodology Top


Patients presenting to a quaternary care teaching hospital with anterior circulation AIS caused by large artery (LA) occlusion within the window period (<4.5 h) with no contraindications for receiving IV-recombinant tPA (rtPA) were considered for sonothrombolysis. As per the hospital protocol, all patients were imaged using various (diffusion-weighted imaging [DWI]/apparent diffusion coefficient [ADC], fluid-attenuated inversion recovery [FLAIR], susceptibility weighted imaging [SWI], and magnetic resonance angiography [MRA]) MR sequences.

All patients received a standard dose of IV-rtPA (0.9 mg/kg body weight) and transcranial Doppler (TCD) ultrasound head frame was fixed immediately. Using a 2 MHz Probe (Nicolet ® SONARA ®, TCD system) [Figure 1], the occluded artery was identified through the temporal window. First, the flow in the proximal part of the occluded artery was identified and then the depth was reduced slowly till absent flow (no regular pulsatile flow signals) was seen at the occluded segment. This occluded segment was continuously resonated. The corresponding segment on the normal side was also identified and the flow monitored and compared with the occluded side. In all cases, the interventional neuroradiologists were informed regarding the potential need for mechanical thrombectomy in case there was no clinical improvement with sonothrombolysis.
Figure 1: Sonothrombolysis with the neurologist monitoring the flow through the occluded artery with intravenous tissue plasminogen activator infusion on flow (Inset: Close up of the attached head frame)

Click here to view


Arterial recanalization was checked and graded using the thrombolysis in brain ischemia (TIBI)[7] flow criteria [Figure 2]. The TCD resonation was continued for the full duration of IV-rtPA infusion even if recanalization was established.
Figure 2: Thrombolysis in brain ischemia grades: (a) Grade 0 (absent flow) - no regular pulsatile flow signals. (b) Grade 1 (minimal flow) - only spikes of systolic flow seen. (c) Grade 2 (blunted flow) - flattened systolic flow with variable acceleration. (d) Grade 3 (dampened flow) - systolic flow acceleration with positive end diastolic velocity. Mean flow velocities is <70% of opposite side (e) Grade 4 (stenotic flow) - the mean flow velocities >30% when compared to opposite side (at least >80 cm/s). (f) Grade 5 (normal flow) - mean flow velocities of at least 70% compared to opposite side

Click here to view


At the end of IV-rtPA infusion, if there was no clinical improvement or no flow was established (TIBI Grade 0 or 1), the patient was immediately imaged using DWI/ADC, FLAIR, SWI, and MRA; also MR perfusion was done in selected cases. If the vessel was still remaining occluded with salvageable parenchyma, the patient was taken up for mechanical thrombectomy.

Arterial recanalization was further evaluated by comparing the pre- and post-treatment time of flight (TOF) – MRAs using a modified thrombolysis in myocardial infarction (TIMI) Score on TOF-MRA.[8] The scoring included the following categories: TIMI 0: no recanalization, TIMI 1: minimal recanalization corresponding to flow signal detectable beyond the area of obstruction but not in most of the distal vascular bed, TIMI 2: partial recanalization defined by an incomplete recanalization but filling most of the vascular bed, and TIMI 3: complete recanalization.

Symptomatic intracranial hemorrhages were defined as intracranial hemorrhage appearing on the follow-up MR imaging (MRI) [SWI]/computed tomography (CT) scans with an increase in National Institutes of Health Stroke Scale (NIHSS) score of ≥4 points.

The extent of parenchymal changes pre- and post-sonothrombolysis was assessed and compared using the CT/DWI-Alberta Stroke Programme Early CT Score (ASPECTS).[9],[10] After discharge, the modified Rankin Scale (mRS)[11] was used to assess the outcome.


 » Results Top


Over a period of 14 months, 18 patients (6 females and 12 males) were treated with sonothrombolysis. The mean age was 55 years (range 32–76 years). Of the 18 patients, 11 (61%) had total anterior circulation involvement and 7 (39%) had partial anterior circulation involvement using the Oxfordshire Community Stroke Project clinical classification (Bamford classification).[12]

Of the 18 patients, 11 (61%) had involvement of the left side and 7 (39%) had right sided involvement. The baseline MRI ASPECTS was above 6 in all patients. Using the TOAST criteria,[11] the etiology was large artery (LA) atherosclerosis in 9 of 18 patients (50%) and cardio-embolic stroke in 8 of 18 patients (44%). One patient was found to have an adenocarcinoma causing a hypercoagulable state.

The mean onset to needle (sonothrombolysis time) was 138 min (range 65–256). A TIBI residual flow [Figure 1] of Grade 2 or more was seen in 15 of 18 patients (83%). In 2 of 18 patients (11%; patients 12 and 17), there was no flow (TIBI 0) at the end of tPA infusion with no clinical improvement [Table 1] (the change in NIHSS was unremarkable). They were immediately imaged using MRI DWI/ADC, FLAIR, and MRA. In one patient, there was no salvageable penumbra and in another, mechanical thrombectomy was done.
Table 1: Stroke etiology, timing, and vessel recanalization of postsonothrombolysis

Click here to view


The NIHSS score improved in all the recanalizers in the immediate sonothrombolysis period and continued to improve except in two patients (patients 10 and 15). These two patients, even though they had a TIBI Grade of 3 and 5, did not show much improvement in their NIHSS [Table 2].
Table 2: Clinical improvement following sonothrombolysis

Click here to view


One patient had a re-occlusion. This patient, who had achieved a TIBI Grade 3 with good clinical improvement (patient 18) immediate postsonothrombolysis, later worsened after 1 h. Repeat imaging was done immediately which showed the vessel remaining occluded; however, the MR perfusion still showed a large salvageable penumbra. This patient was also taken up for mechanical thrombectomy with a good outcome.

Follow-up MRI with MRA was done in 14 of 18 patients (78%) and in the remaining, only a noncontrast CT scan was done within 24 h. Of the 14 patients, 8 (57%) had a TIMI of 2 or more (partial to complete recanalization) [Figure 3]. It was also noted that in cases where the internal carotid artery (ICA) was occluded with the thrombus extending to the proximal middle cerebral artery (MCA), sonothrombolysis achieved flow in the MCA (with collateral blood from the circle of Wills); however, there was little effect on the occluded ICA itself with only 1 of 5 patients (20%) of the occluded ICA showing flow.
Figure 3: (a) Diffusion restriction in the right insular cortex and lateral temporal parietal lobe with (b) complete cut-off of the proximal M1 segment. Postsonothrombolysis (c) good recanalization in the middle cerebral artery of thrombolysis in myocardial infarction - Grade 3 (d) no further increase in the areas of diffusion restriction

Click here to view


Hemorrhage was seen in 3 patients (16%). Only one was symptomatic (5.5%). There were 2 deaths (11%). One patient who failed sonothrombolysis did not show recanalization even after attempting mechanical thrombectomy. This patient was subsequently diagnosed to have a disseminated adenocarcinoma. The second mortality was in a patient who had failed sonothrombolysis and was not considered for mechanical thrombectomy as the subsequent MRI did not show a demonstrable penumbra. This patient subsequently improved to an NIHSS of 10, but died following aspiration pneumonia and septic shock.

At 6 months, out of the remaining 16 patients, one patient was lost for follow-up. Of the 15 patients, 10 (67%) had a mRS of 2 or less.


 » Discussion Top


Since the 1970s, the ability of ultrasound waves (USW) to enhance clot lysis was noted in experimental animal studies.[12] It was observed by Alexandrov's group in Houston that patients being monitored with 2 MHz TCD during IV tPA infusion had a better outcome. This paved the way for therapeutic use of ultrasound in AIS treatment and clinical trials looking at the benefit of sonothrombolysis.[13] It has been shown that ultrasound in combination with rtPA can drastically increase the rate at which a blood clot dissolves.[14],[15]

USWs can accelerate clot lysis through multiple mechanisms. USW can break the molecular linkages of fibrin polymers, thus increasing the penetration of IV tPA and also exposing more areas of the clot to the action of IV tPA.[16] When a clot forms, there will be some microbubbles which will get trapped inside. When the clot is exposed to pulsed USW, these microbubbles can have repeating oscillations. This is termed as stable cavitation (since these microbubbles do not collapse).[17] This repeated oscillations will lead to a process called acoustic microstreaming caused by shear stress by a gas body oscillating near a rigid structure (here the arterial wall); this microstreaming can enhance the effects of the IV tPA.[18],[19] As the USW pressure increases, the cavitation becomes unstable, leading to destruction of the gas bubble. This is called inertial cavitation (unstable cavitation), which can cause violent collapse of the microbubble producing shock waves and micro jets. This can agitate the clot but can also cause potential damage to the adjacent tissues.[20] Ultrasound can also increase the activity of the endothelial nitric oxide syntheses and increase the nitric oxide release leading on to vasodilatation and improvement in the microcirculation.[21]

In the phase II clinical randomized multicenter international trial, using the combined lysis of thrombus in brain ischemia using transcranial ultrasound and systemic tPA (CLOTBUST) trial,[22] patients with MCA occlusions were randomized to receive sonothrombolysis. This study showed complete recanalization on TCD or dramatic clinical recovery with a total NIHSS score ≤3 points or improvement by ≥10 NIHSS points within 2 h after tPA bolus in 49% versus 30% of the control patients receiving only tPA (P = 0·03).

In our series, such dramatic improvement was seen in 6 of 18 patients (30%) on immediate postsonothrombolysis, and by the next 24 h (50%), 9 of 18 patients had achieved an NIHSS score ≤3 points or improvement by ≥ 10 NIHSS.

In the CLOTBUST trial where a 2 MHz TCD was used, there was no increase in the rate of symptomatic intracerebral hemorrhage (4·8% in both arms). However, when nondiagnostic 3.30 KHz ultrasound was used with the aim of increasing the recanalization rate in the transcranial low-frequency ultrasound mediated TIBI trial, symptomatic hemorrhage occurred in 36%. It is interesting to note that in this trial, hemorrhages occurred even in areas not affected by ischemia.[23] In our series where 2 MHz TCD was used, the symptomatic ICH rate was 5.5% (1/18).

Most of the mechanisms that promote clot lysis can be amplified by the co-administration of microbubbles. These are small, gas-filled microspheres with an inert gas core and a biodegradable shell. They are small enough to pass through all major and minor capillaries of the human body and reach the clot in the occluded segment to interact with the ultrasonic source to augment the process of sonothrombolysis.[24],[25] Most of the clinical trials on sonothrombolysis using microbubbles have used the common diagnostic galactose-based microbubbles given in bolus.[26] The concomitant use of microbubbles to augment recanalization was also seen to be associated with a slightly higher hemorrhage rates.[27],[28] The increase in the hemorrhagic transformation is due to the endothelial damage caused by the unstable cavitation of the microbubbles leading to blood–brain barrier disruption.[29]

Only ultrasound targeting of the intra-arterial thrombus without using thrombolytics is termed sonolysis. This may be an option for patients ineligible for rtPA.[30],[31] A randomized controlled trial to test the superiority of both microbubbles enhanced sonothrombolysis and sonolysis is underway.[32]

Systematic reviews and meta-analyses show that sonothrombolysis is safe and effective in reducing death or dependency at 3 months by increasing the recanalization rate in AIS.[33],[34],[35]

In clinical practice, sonothrombolysis requires trained personnel to identify the occluded intracranial artery, deliver the ultrasound through the appropriate cranial window, and pick up the recanalization. This limits the use of this therapy to selected specialized stroke treatment centers. To overcome this, a device which can be easily attached to a patient's head to deliver 2 MHz ultrasound pulsed-waves has been developed. This device is currently being tested in an ongoing phase III efficacy trial.[36]

We had treated these patients before the American Heart Association/American Stroke Association released their focused update of the 2013 guidelines for the early management of patients with AIS with endovascular treatment.[37] Even though the latest recommendation for anterior circulation ischemic strokes caused by LA occlusion is a mechanical thrombectomy device over IV thrombolysis, in resource-scarce countries like ours, facilities for intra-arterial thrombolysis are not widely available. In centers where only IV tPA is available and are far away from hospitals offering endovascular therapy and also in centers offering the drip and ship option [38] to a nearby tertiary center, sonothrombolysis can be an easily affordable and cheap way to improve the efficacy of IV tPA.

Acknowledgment

The authors acknowledge the contribution of Mr. Panickar Anbalagan M. Sc., for his help during administering sonothrombolysis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
 » References Top

1.
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.  Back to cited text no. 1
    
2.
Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Liang S, et al. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol 2013;70:353-8.  Back to cited text no. 2
    
3.
Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 2010;41:2254-8.  Back to cited text no. 3
    
4.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20.  Back to cited text no. 4
    
5.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019-30.  Back to cited text no. 5
    
6.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285-95.  Back to cited text no. 6
    
7.
Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, et al. Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89-93.  Back to cited text no. 7
    
8.
Pauline R, Thomas T, Julien A, Luc B, Alexandre V, François R, et al. TOF-MRA is reliable to evaluate the degree of MCA obstruction in acute stroke: An inter- and intra-observer study. Int J Diagn Imaging 2014;12:10-17.  Back to cited text no. 8
    
9.
Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4.  Back to cited text no. 9
    
10.
de Margerie-Mellon C, Turc G, Tisserand M, Naggara O, Calvet D, Legrand L, et al. Can DWI-ASPECTS substitute for lesion volume in acute stroke? Stroke 2013;44:3565-7.  Back to cited text no. 10
    
11.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-7.  Back to cited text no. 11
    
12.
Trübestein G, Engel C, Etzel F, Sobbe A, Cremer H, Stumpff U. Thrombolysis by ultrasound. Clin Sci Mol Med Suppl 1976;3:697s-8s.  Back to cited text no. 12
    
13.
Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000;31:610-4.  Back to cited text no. 13
    
14.
Holland CK, Vaidya SS, Datta S, Coussios CC, Shaw GJ. Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model. Thromb Res 2008;121:663-73.  Back to cited text no. 14
    
15.
Stone MJ, Frenkel V, Dromi S, Thomas P, Lewis RP, Li KC, et al. Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. Thromb Res 2007;121:193-202.  Back to cited text no. 15
    
16.
Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. Binding of tissue-plasminogen activator to fibrin: Effect of ultrasound. Blood 1998;91:2019-25.  Back to cited text no. 16
    
17.
Williams AR, Hughes DE, Nyborg WL. Hemolysis near a transversely oscillating wire. Science 1970;169:871-3.  Back to cited text no. 17
    
18.
Rooney JA. Hemolysis near an ultrasonically pulsating gas bubble. Science 1970;169:869-71.  Back to cited text no. 18
    
19.
Rooney JA. Shear as a mechanism for sonically induced biological effects. J Acoust Soc Am 1972;52:1718-24.  Back to cited text no. 19
    
20.
Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol 2000;26:1153-60.  Back to cited text no. 20
    
21.
Sugita Y, Mizuno S, Nakayama N, Iwaki T, Murakami E, Wang Z, et al. Nitric oxide generation directly responds to ultrasound exposure. Ultrasound Med Biol 2008;34:487-93.  Back to cited text no. 21
    
22.
Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-8.  Back to cited text no. 22
    
23.
Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, et al. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: Increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: Results of a phase II clinical trial. Stroke 2005;36:1441-6.  Back to cited text no. 23
    
24.
Culp WC, Porter TR, Lowery J, Xie F, Roberson PK, Marky L. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke 2004;35:2407-11.  Back to cited text no. 24
    
25.
Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995;92:1148-50.  Back to cited text no. 25
    
26.
Molina CA, Ribo M, Rubiera M, Montaner J, Santamarina E, Delgado-Mederos R, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 2006;37:425-9.  Back to cited text no. 26
    
27.
Larrue V, Viguier A, Arnaud C, Cognard C, Petit R, Rigal M, et al. Transcranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke: A randomized controlled study. Stroke 2007;38:472.  Back to cited text no. 27
    
28.
Molina CA, Barreto AD, Tsivgoulis G, Sierzenski P, Malkoff MD, Rubiera M, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol 2009;66:28-38.  Back to cited text no. 28
    
29.
Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 2007;93:354-62.  Back to cited text no. 29
    
30.
Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke 2002;33:626-8.  Back to cited text no. 30
    
31.
Dwedar AZ, Ashour S, Haroun M, El Nasser AA, Moustafa RR, Ibrahim MH, et al. Sonothrombolysis in acute middle cerebral artery stroke. Neurol India 2014;62:62-5.  Back to cited text no. 31
[PUBMED]  Medknow Journal  
32.
Nacu A, Kvistad CE, Logallo N, Naess H, Waje-Andreassen U, Aamodt AH, et al. A pragmatic approach to sonothrombolysis in acute ischaemic stroke: The Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS). BMC Neurol 2015;15:110.  Back to cited text no. 32
    
33.
Ricci S, Dinia L, Del Sette M, Anzola P, Mazzoli T, Cenciarelli S, et al. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2012;10:CD008348.  Back to cited text no. 33
    
34.
Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007;38:967-73.  Back to cited text no. 34
    
35.
Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging 2014;24:209-20.  Back to cited text no. 35
    
36.
Barreto AD, Alexandrov AV, Shen L, Sisson A, Bursaw AW, Sahota P, et al. CLOTBUST-hands free: Pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke. Stroke 2013;44:3376-81.  Back to cited text no. 36
    
37.
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:3020-35.  Back to cited text no. 37
    
38.
Sheth KN, Smith EE, Grau-Sepulveda MV, Kleindorfer D, Fonarow GC, Schwamm LH. Drip and ship thrombolytic therapy for acute ischemic stroke: Use, temporal trends, and outcomes. Stroke 2015;46:732-9.  Back to cited text no. 38
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow